NEW YORK, Aug. 7 – Microfluidics startup Fluidigm has appointed Douglas Modlin to the position of chief technology officer and vice president of research and development, the company said on Tuesday.  

Modlin previously served as vice president of instrumentation technology research and development at Molecular Devices Corporation. He has also worked in various capacities at LJL BioSystems, Affymax, and Affymetrix.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.